Kewaunee Scientific(DE:KEW)
€31.40-0.60 (-1.88%)
DE:KEW
Kewaunee Scientific financials statements
€31.40
At close:-0.60 (-1.88%)
Kewaunee Scientific (KEW) Ratios
2 Followers
Kewaunee Scientific Ratios
DE:KEW's free cash flow for Q1 2027 was $1.20M. For the 2027 fiscal year, DE:KEW's free cash flow was decreased by $-772.00K and operating cash flow was $1.98M. See a summary of the company’s cash flow.
| Ratios | Apr 26 | Apr 25 | Apr 24 | Apr 23 | Apr 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.18 | 2.20 | 2.37 | 2.20 | 2.17 |
| Quick Ratio | 1.55 | 1.59 | 1.87 | 1.65 | 1.60 |
| Cash Ratio | 0.24 | 0.28 | 0.57 | 0.20 | 0.10 |
| Solvency Ratio | 0.16 | 0.13 | 0.28 | 0.05 | -0.04 |
| Operating Cash Flow Ratio | 0.39 | 0.28 | 0.48 | -0.09 | -0.19 |
| Short-Term Operating Cash Flow Coverage | 3.75 | 3.80 | 6.31 | -1.06 | -3.65 |
| Net Current Asset Value | $ 3.90M | $ -10.05M | $ 18.26M | $ 7.51M | $ 8.97M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.26 | 0.08 | 0.11 | 0.57 |
| Debt-to-Equity Ratio | 0.40 | 0.78 | 0.20 | 0.35 | 1.89 |
| Debt-to-Capital Ratio | 0.29 | 0.44 | 0.17 | 0.26 | 0.65 |
| Long-Term Debt-to-Capital Ratio | 0.17 | 0.34 | 0.00 | 0.43 | 0.45 |
| Financial Leverage Ratio | 2.39 | 3.02 | 2.46 | 3.18 | 3.33 |
| Debt Service Coverage Ratio | 2.33 | 2.75 | 4.90 | 0.94 | -0.93 |
| Interest Coverage Ratio | 4.33 | 5.53 | 10.16 | 2.09 | -4.13 |
| Debt to Market Cap | 0.19 | 0.42 | 0.03 | 0.72 | 0.78 |
| Interest Debt Per Share | 11.89 | 18.65 | 4.45 | 5.19 | 24.48 |
| Net Debt to EBITDA | 0.78 | 1.55 | -0.68 | 0.59 | 68.92 |
| Profitability Margins | |||||
| Gross Profit Margin | 28.52% | 28.63% | 25.55% | 16.21% | 14.34% |
| EBIT Margin | 6.24% | 7.48% | 7.32% | 2.41% | -1.10% |
| EBITDA Margin | 8.47% | 9.46% | 8.86% | 3.72% | 0.54% |
| Operating Profit Margin | 5.93% | 7.39% | 8.97% | 1.65% | -1.54% |
| Pretax Profit Margin | 4.87% | 6.15% | 6.44% | 2.05% | -1.47% |
| Net Profit Margin | 3.41% | 4.74% | 9.20% | 0.62% | -3.55% |
| Continuous Operations Profit Margin | 3.71% | 4.82% | 9.35% | 0.62% | -3.55% |
| Net Income Per EBT | 70.04% | 77.14% | 142.95% | 30.21% | 241.57% |
| EBT Per EBIT | 82.16% | 83.25% | 71.76% | 123.84% | 95.28% |
| Return on Assets (ROA) | 5.39% | 5.86% | 13.92% | 1.14% | -5.05% |
| Return on Equity (ROE) | 12.87% | 17.69% | 34.25% | 3.63% | -16.82% |
| Return on Capital Employed (ROCE) | 12.86% | 12.60% | 19.45% | 4.61% | -3.41% |
| Return on Invested Capital (ROIC) | 9.18% | 9.39% | 18.41% | 1.30% | -3.26% |
| Return on Tangible Assets | 6.43% | 6.94% | 13.92% | 1.13% | -5.00% |
| Earnings Yield | 9.08% | 12.58% | 18.25% | 3.08% | -15.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.80 | 3.85 | 4.52 | 4.76 | 3.09 |
| Payables Turnover | 8.98 | 6.35 | 6.52 | 7.79 | 5.30 |
| Inventory Turnover | 6.60 | 5.22 | 7.34 | 8.40 | 6.08 |
| Fixed Asset Turnover | 8.50 | 6.65 | 8.12 | 8.58 | 7.44 |
| Asset Turnover | 1.58 | 1.24 | 1.51 | 1.85 | 1.42 |
| Working Capital Turnover Ratio | 4.63 | 3.99 | 3.92 | 4.52 | 4.47 |
| Cash Conversion Cycle | 90.65 | 107.06 | 74.51 | 73.23 | 109.37 |
| Days of Sales Outstanding | 76.03 | 94.69 | 80.73 | 76.63 | 118.25 |
| Days of Inventory Outstanding | 55.29 | 69.87 | 49.75 | 43.44 | 60.04 |
| Days of Payables Outstanding | 40.66 | 57.50 | 55.97 | 46.84 | 68.93 |
| Operating Cycle | 131.32 | 164.55 | 130.48 | 120.07 | 178.30 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 6.51 | 5.17 | 6.80 | -1.34 | -2.83 |
| Free Cash Flow Per Share | 5.13 | 4.41 | 5.28 | -2.81 | -3.52 |
| Dividend Paid and CapEx Coverage Ratio | 4.73 | 6.83 | 4.47 | -0.91 | -4.13 |
| Capital Expenditure Coverage Ratio | 4.73 | 6.83 | 4.47 | -0.91 | -4.13 |
| Operating Cash Flow Coverage Ratio | 0.62 | 0.29 | 1.78 | -0.29 | -0.12 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.06 | 0.10 | -0.02 | -0.05 |
| Free Cash Flow Yield | 13.87% | 13.92% | 14.78% | -18.01% | -24.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 11.01 | 7.96 | 5.48 | 32.43 | -6.62 |
| Price-to-Sales (P/S) Ratio | 0.38 | 0.38 | 0.50 | 0.20 | 0.24 |
| Price-to-Book (P/B) Ratio | 1.42 | 1.41 | 1.88 | 1.18 | 1.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.21 | 7.18 | 6.77 | -5.55 | -4.06 |
| Price-to-Operating Cash Flow Ratio | 5.69 | 6.13 | 5.25 | -11.63 | -5.04 |
| Price-to-Earnings Growth (PEG) Ratio | -0.71 | -0.20 | 0.00 | -0.27 | -0.10 |
| Enterprise Value Multiple | 5.22 | 5.53 | 5.02 | 5.99 | 112.29 |
| Enterprise Value | 124.53M | 125.85M | 90.52M | 48.91M | 102.86M |
| EV to EBITDA | 5.22 | 5.53 | 5.02 | 5.99 | 112.29 |
| EV to Sales | 0.44 | 0.52 | 0.44 | 0.22 | 0.61 |
| EV to Free Cash Flow | 8.47 | 9.97 | 5.96 | -6.16 | -10.50 |
| EV to Operating Cash Flow | 6.68 | 8.51 | 4.63 | -12.91 | -13.05 |
| Tangible Book Value Per Share | 16.78 | 12.55 | 19.52 | 13.63 | 12.99 |
| Shareholders’ Equity Per Share | 26.10 | 22.52 | 19.02 | 13.25 | 12.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.22 | -0.45 | 0.70 | -1.42 |
| Revenue Per Share | 98.50 | 84.02 | 70.77 | 77.72 | 60.61 |
| Net Income Per Share | 3.36 | 3.98 | 6.51 | 0.48 | -2.15 |
| Tax Burden | 0.70 | 0.77 | 1.43 | 0.30 | 2.42 |
| Interest Burden | 0.78 | 0.82 | 0.88 | 0.85 | 1.34 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| SG&A to Revenue | 0.23 | 0.21 | 0.18 | 0.14 | 0.16 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Income Quality | 1.78 | 1.28 | 1.04 | -2.79 | 1.31 |
Currency in USD

